The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD in August 2024, and as of mid-2026 that decision stands. MDMA remains a Schedule I substance in the United States, meaning the only legal access pathways are through active...
This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded in current clinical research, verified legal data, and practical...
Psychedelic tourism is growing fast, and so is the number of people booking retreats abroad with little more than a website and a payment link between them and a high-dose experience. Psychedelic retreat abroad safety depends heavily on who is running the program,...
Last Updated: May 2026 Is psychedelic therapy legal in the USA? The honest answer is: it depends entirely on where you live and what substance you are asking about. Oregon, Colorado, and New Mexico have licensed psilocybin programs for supervised adult use. Everywhere...
Psychedelic policy in the USA is moving faster in 2026 than at any point in recent history. A federal executive order, a wave of state-level bills, and advancing clinical trials have all converged in the first half of this year. This guide covers the key federal...
Psychedelic therapy in Washington state is an evolving picture. Ketamine is fully legal and widely available across Seattle and the broader Puget Sound area. Psilocybin remains legally off-limits for now, though the legislature has been actively working on medical...
